© Copyright Africa Health IT News © 2023
Friday, April 19
Home›Global Health›Groups Push to Reverse FDA on Zohydro
Global Health

Groups Push to Reverse FDA on Zohydro

AHIT
February 26, 2014
0
802
Spread the love

(MedPage Today) — A coalition of several advocacy groups wants to reinforce a message sent to FDA by other key policymakers: rescind approval of the powerful painkiller Zohydro. …read more    

Previous Article

RA-Lymphoma Risk: Biologics Not to Blame (CME/CE)

Next Article

FDA Panel Skeptical of Primatene Remake (CME/CE)

AHIT

Comments are closed.

More News

Get daily news updates to your inbox!

Subscribe to our mailing list to receives daily updates direct to your inbox!

© Copyright Africa Health IT News. All Rights Reserved.